Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Trevi Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 11.51 | 10.24 | 10.07 | 9.49 | 10.16 | 7.31 | |
Research & Development | 31.67 | 23.68 | 19.83 | 22.98 | 22.33 | 19.34 | |
Operating Expenses | 43.17 | 33.92 | 29.91 | 32.48 | 32.49 | 26.65 | |
Operating Income | -43.17 | -33.92 | -29.91 | -32.48 | -32.49 | -26.65 | |
Interest Expense | -0.01 | -0.39 | -1.16 | -1.2 | -0.46 | - | |
Interest & Investment Income | 4.25 | 4.75 | 1.74 | 0.01 | 0.18 | 0.79 | |
Other Non Operating Income (Expenses) | 0.15 | 0.47 | 0.14 | -0.29 | -0.01 | -0.22 | |
EBT Excluding Unusual Items | -38.78 | -29.1 | -29.19 | -33.96 | -32.78 | -26.07 | |
Pretax Income | -38.78 | -29.1 | -29.19 | -33.96 | -32.78 | -26.07 | |
Income Tax Expense | -0.01 | -0.03 | -0.04 | -0.02 | -0.02 | -0.02 | |
Net Income | -38.77 | -29.07 | -29.15 | -33.94 | -32.76 | -26.05 | |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.7 | |
Net Income to Common | -38.77 | -29.07 | -29.15 | -33.94 | -32.76 | -26.75 | |
Shares Outstanding (Basic) | 100 | 99 | 65 | 23 | 18 | 12 | |
Shares Outstanding (Diluted) | 100 | 99 | 65 | 23 | 18 | 12 | |
Shares Change (YoY) | 9.43% | 53.44% | 182.56% | 26.48% | 53.88% | 2581.79% | |
EPS (Basic) | -0.39 | -0.29 | -0.45 | -1.49 | -1.81 | -2.28 | |
EPS (Diluted) | -0.39 | -0.29 | -0.45 | -1.49 | -1.81 | -2.28 | |
Free Cash Flow | -32.86 | -31.85 | -28.33 | -28.95 | -29.03 | -23.1 | |
Free Cash Flow Per Share | -0.33 | -0.32 | -0.44 | -1.27 | -1.61 | -1.97 | |
EBITDA | -43.03 | -33.8 | -29.86 | -32.43 | -32.44 | -26.61 | |
D&A For EBITDA | 0.14 | 0.12 | 0.04 | 0.05 | 0.05 | 0.04 | |
EBIT | -43.17 | -33.92 | -29.91 | -32.48 | -32.49 | -26.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.